Current developments for targeting the TRAIL pathway show promise for cancer therapies, but a deeper understanding of the TRAIL DISC composition and stoichiometry will be crucial for the development of effective TRAIL-based therapeutic approaches. Here, TNFSF10 is linked to cancer.